2.
Jay Patel 2
Pfizer Inc.
Table of Contents
Table of Contents................................................................................................................................................... 2
Executive Summary .............................................................................................................................................. 3
Company Profile ................................................................................................................................................... 4
Industry Profile ..................................................................................................................................................... 5
Current Events ...................................................................................................................................................... 6
Outlook................................................................................................................................................................... 7
Recommendation................................................................................................................................................... 8
Resources ............................................................................................................................................................... 9
3.
Jay Patel 3
Pfizer Inc.
Executive Summary
Pfizer researches, develops, and manufactures pharmaceutical drugs.
The mission of Pfizer's office of Independent Grants for Learning & Change (IGL&C), formerly Medical
Education Group (MEG), is to cooperate with health care delivery organizations and professional associations
to narrow professional practice gaps in areas of mutual interest through support of learning and change
strategies that result in measurable improvement in competence, performance or patient outcomes.1
The stock of Pfizer has been increasing over the past 5 years and Pfizer is the top company out of its
competitors.
Pfizer is prioritizing its research and development efforts in areas with the greatest scientific and commercial
promise: immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and
pain, and vaccines. Through major research efforts across multiple modalities — including small molecules,
biologics and vaccines — Pfizer is developing the medical solutions that will matter most to the people we
serve. Specialized efforts in biosimilars as well as orphan and genetic diseases also illustrate our dedication to
develop and deliver innovative medicines and vaccines that will benefit patients around the world.2
1 Pfizer Mission Statement –Source 5
2 Pfizer Pipeline –Source 5
4.
Jay Patel 4
Pfizer Inc.
Company Profile
Ticker Symbol:
PFE
Mission Statement:
“Our mission is to apply science and our global resources to improve health and well-being at every stage of life. We strive to
set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and
animals. Our diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and
vaccines, as well as many of the world’s best-known consumer products.Every day, we work across developed and
emerging markets to advance wellness, prevention,treatments and cures that challenge the most feared diseas es ofour time.
We also collaborate with healthcare providers, governments and local communities to support and expand access to reliable,
affordable healthcare around the world. Our revenues are derived from the sale of our products,as well as through alliance
agreements, under which we co-promote products discovered by other companies (Alliance revenues)”
Location of Corporate Headquarters:
New York City, NY
Date of Incorporation:
June 2, 1942
Public Auditor:
KPMG
Name of CEO (Chief Executive Officer):
Ian Read
Name of CFO (Chief Financial Officer):
Frank D’Amelio
Stock Classification:
Common Stock
Dividends:
$6,004,610.16
5.
Jay Patel 5
Pfizer Inc.
Industry Profile
Market Sector
Pfizer belongs to the market sectorof Health Care. A market sector is an area of the economy where the businesses in that specific
area produce the same or a related product or service. They are the businesses that share the same characteristics. Investors usually use
a business’s sectorto place stocks and other investments into categories.
Industry Leaders Industry Laggards
The Procter & Gamble Company HST Global
Johnson & Johnson Tongli Pharmaceuticals
Pfizer Znomics
Industry
The industry that Pfizer belongs to is pharmaceutical manufacturing. To be categorized into this industry, the business’s primary focus
should be on manufacturing and selling pharmaceutical products.Pharmaceutical products include drugs and medicine.
Stock Performance
In this graph Pfizer is compared to its three major competitor: Novartis (NVS), Merck & Co. (MRK), and Sanofi (SNY).
6.
Jay Patel 6
Pfizer Inc.
Observations
According the pie chart, Pfizer’s value is greater than all
of its top competitors. However, there isn’t a large
difference between the four companies. Market
capitalization is the total market value of all of a
company’s outstanding shares measured in dollars.
Simplified, it is an estimation of the value of the
business.The value is calculated by multiplying the
number of outstanding shares by the current price of the
share.
Current Events
Event #1 (Domestic): Pfizer third-quarter profit beats estimates, oncology drugsshine
Pfizer reported higher earning than expected in their third quarter. This increase happened because of cost cutting and a lower
tax rate. It is expect that Pfizer will continue to improve though.“Saftlas raised his 12-month share-price target on Pfizer to
$35, from $33, saying the company will report data in coming months from trials of a number of promising experimental
drugs and from studies testing new uses ofits already marketed drugs.” I chose this article because it gives reasons for why
Pfizer will continue to improve in the long-term.
o http://www.reuters.com/article/2013/10/29/us-pfizer-results-idUSBRE99S0I220131029
Event #2 (Global): Pfizer’s second UK INSPIRE site goes to Scotland
Four Scottish health boards have come togetherto become Pfizer’s second UK Inspire site. Inspire is a strategic network of
sites that are highly productive and effective in conducting clinical trials. “Under the Scottish programme, Pfizer and the
health boards will share expert knowledge and experience in research to help bring new medicines to patients in Scotland, the
UK and around the world, the partners said.” I chose this article because it shows how people are reaching out to Pfizer for
this program. This program will help Pfizer and everyone around the world, in the long-term.
o http://www.pharmatimes.com/article/13-11-05/Pfizer_s_second_UK_INSPIRE_site_goes_to_Scotland.aspx
7.
Jay Patel 7
Pfizer Inc.
Outlook
I believe that the next one to three years, the industry of health will only improve. In today’s world, health is
everything because no one just wants to die. There are many diseases, infections, viruses, and other medical
issues that don’t have a cure. The health care industry will continue to thrive, until something is made that cures
everything. As for Pfizer, I believe that they will become one of the dominant company’s in this industry. Their
current initiative for the pipeline with brings them to the next level for medicine. They are current focused on
creating and developing things for immunology and inflammation, oncology, cardiovascular and metabolic
diseases, neuroscience and pain, and vaccines. Over the past five years Pfizer has been growing in a positive
direction and it should continue to do so in the future.
8.
Jay Patel 8
Pfizer Inc.
Recommendation
I believe that Pfizer is a good investment and it should be bought. Pfizer is currently working on a pipeline of new drugs
that could be revolutionary. If these drugs are successfulthe stock price will stock price will sky rocket because they will
be the first in the market.
Liquidity refers to how fast an asset can be converted to cash. Pfizer experienced an increase in their current ratio over the
two-year period. Pfizer has a current ratio of 2.15 at the end of 2012. This means that it is considered a safe risk for
lenders granting short-term credit because if problems do come up, Pfizer will be able to pay off its debts quickly and
continue to function as a company.
Debt to equity ratio measures the degree to which the company is financed by borrowed funds that it must repay. The
company did not experience an increase or decrease over the two years. These ratios tell lenders and investors whether or
not it is a risky firm. However with a ratio of 1.29, Pfizer seems to be a considerably stable company.
Profit margin is the amount by which revenue from sales exceeds costs. Pfizer had a high increase in the profit margin
ratio over the period of two years. 0.25 is a huge profit margin. Pfizer makes about $0.25 per dollar of sales. Compared to
most companies, this is a profit margin that is very large. It means that Pfizer will continue to have a health long-term
performance because it is making a lot of money from its sales.
The graph below shows that Pfizer has been increasing at a steady rate for the past 5 years. Over the past 3 years Pfizer’s
stock price has almost doubled. It is a health company that will make for a good investment.
9.
Jay Patel 9
Pfizer Inc.
Resources
1. "Bloomberg." Bloomberg.com. Bloomberg. 10 Nov. 2013 <http://www.bloomberg.com/>.
2. "Google Finance: Stock market quotes, news, currency conversions & more." Google Finance: Stock
market quotes, news, currency conversions & more. 10 Nov. 2013 <http://finance.google.com/>.
3. "Hoovers | Company Information | Industry Information | Lists." Hoovers | Company Information |
Industry Information | Lists. 10 Nov. 2013 <http://www.hoovers.com/>.
4. "Industry Center Performance information for over 210 industries - Yahoo Finance." Industry Center
Performance information for over 210 industries - Yahoo Finance. 10 Nov. 2013
<http://biz.yahoo.com/ic/>.
5. "Pfizer: The world's largest research-based pharmaceutical company." Pfizer: The world's largest
research-based pharmaceutical company. 10 Nov. 2013 <http://www.pfizer.com/>.
